Professor Varda Shoshan-Barmatz of Israel’s Ben Gurion University has developed many new treatments to kill cancer cells by targeting the protein VDAC1 that controls cell death. A new Israeli biotech, Vidac, is trialing these treatments. VDA-1102 ointment for pre-skin cancer is in Phase 2.

https://aabgu.org/targeting-brain-cancer/ http://www.vidacpharma.com/pipeline-vidac-pharma